9月17日，南方航空盘中上涨2.15%，截至10:30，报6.18元/股，成交3.40亿元，换手率0.44%，总市值 1119.87亿元。 分红方面，南方航空A股上市后累计派现66.29亿元。近三年，累计派现0.00元。 机构持仓方面，截止2025年6月30日，南方航空十大流通股东中，香港中央结算有限公司位居第四大流 通股东，持股5.82亿股，相比上期减少264.86万股。华泰柏瑞沪深300ETF（510300）位居第九大流通股 东，持股9631.78万股，相比上期增加798.68万股。易方达沪深300ETF（510310）位居第十大流通股 东，持股6847.02万股，相比上期增加665.94万股。 责任编辑：小浪快报 资料显示，中国南方航空股份有限公司位于广东省广州市白云区齐心路68号中国南方航空大厦，成立日 期1995年3月25日，上市日期2003年7月25日，公司主营业务涉及国内和经批准的国际、地区航空客、 货、邮、行李运输业务,通用航空业务等。主营业务收入构成为：服务86.42%，货运及邮运10.52%，其 他(补充)3.06%。 南方航空所属申万行业为：交通运输-航空机场-航空运输。所属概念板块包括 ...

Group 1 - The stock price of Huaxin Cement fell by 2.02% on September 17, trading at 17.48 yuan per share with a total market capitalization of 36.341 billion yuan [1] - Year-to-date, Huaxin Cement's stock price has increased by 50.17%, with a 6.65% rise in the last five trading days and a 12.27% increase over the last 20 days [1] - The company has appeared on the trading leaderboard three times this year, with the most recent instance on July 25, where it recorded a net buy of -168 million yuan [1] Group 2 - Huaxin Cement, established on November 30, 1993, and listed on January 3, 1994, is primarily engaged in cement manufacturing and sales, with cement sales accounting for 54.56% of its revenue [2] - As of June 30, 2025, Huaxin Cement reported a revenue of 16.047 billion yuan, a year-on-year decrease of 1.17%, while its net profit attributable to shareholders increased by 51.05% to 1.103 billion yuan [2] - The company has distributed a total of 13.594 billion yuan in dividends since its A-share listing, with 3.127 billion yuan distributed in the last three years [3] Group 3 - As of June 30, 2025, Huaxin Cement had 45,700 shareholders, an increase of 6.56% from the previous period [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 56.9032 million shares, a decrease of 6.6314 million shares from the previous period [3] - The Southern CSI 500 ETF is a new entrant among the top ten shareholders, holding 9.995 million shares [3]

Company Overview - Yirui Technology, established on March 7, 2011, and listed on September 18, 2020, is located in Shanghai and specializes in the research, production, sales, and service of digital X-ray detectors [1] - The company's main revenue sources include detector sales (81.21%), core component sales (7.66%), solution/technical service income (5.89%), accessory sales (4.57%), and rental income (0.66%) [1] Financial Performance - As of June 30, 2025, Yirui Technology reported a revenue of 1.067 billion yuan, representing a year-on-year growth of 3.94%, and a net profit attributable to shareholders of 335 million yuan, with an increase of 8.82% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 789 million yuan, with 557 million yuan distributed over the past three years [3] Stock Market Activity - On September 17, Yirui Technology's stock price decreased by 2.02%, trading at 112.33 yuan per share, with a total market capitalization of 22.491 billion yuan [1] - The stock has seen a year-to-date increase of 66.23%, with a 1.95% rise over the last five trading days, 1.98% over the last twenty days, and 24.88% over the last sixty days [1] - As of June 30, 2025, the number of shareholders increased by 21.67% to 6,990, with an average of 28,643 circulating shares per shareholder, up 15.02% [2] Institutional Holdings - As of June 30, 2025, the ninth largest circulating shareholder is Huabao Zhongzheng Medical ETF, holding 3.926 million shares as a new shareholder, while the Invesco Great Wall New Energy Industry Stock A Class has exited the top ten circulating shareholders [3]

Core Viewpoint - The stock of Weili Transmission has experienced fluctuations, with a recent decline of 2.13% and a year-to-date increase of 12.81%, indicating volatility in the market performance of the company [1] Company Overview - Weili Transmission, established on October 29, 2003, is located in Yinchuan, Ningxia, and specializes in the research, production, and sales of wind power gearboxes [1] - The company was listed on August 9, 2023, and its main business revenue composition is 98.23% from wind power gearboxes and 1.77% from other sources [1] Financial Performance - For the first half of 2025, Weili Transmission reported a revenue of 350 million yuan, reflecting a year-on-year growth of 113.17%, while the net profit attributable to shareholders was a loss of 43.51 million yuan, a decrease of 343.76% compared to the previous period [2] - Since its A-share listing, the company has distributed a total of 73.11 million yuan in dividends [3] Shareholder Information - As of June 30, 2025, the number of shareholders for Weili Transmission was 8,066, a decrease of 4.67% from the previous period, with an average of 2,725 circulating shares per shareholder, an increase of 4.90% [2] - Notable institutional shareholders include Noan Pioneer Mixed A, which increased its holdings by 39,540 shares, and other funds that have seen changes in their shareholdings [3]

Core Viewpoint - Furan De has shown significant stock price appreciation and strong financial performance, indicating potential growth in the logistics supply chain services sector for high-end automotive and home appliance industries [1][2]. Group 1: Stock Performance - On September 16, Furan De's stock rose by 2.03%, reaching 22.09 CNY per share, with a trading volume of 288 million CNY and a turnover rate of 2.70%, resulting in a total market capitalization of 10.887 billion CNY [1]. - Year-to-date, Furan De's stock price has increased by 136.23%, with recent gains of 8.02% over the last five trading days, 45.23% over the last 20 days, and 63.98% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with the latest appearance on August 12, where it recorded a net purchase of 20.9144 million CNY [1]. Group 2: Company Overview - Furan De, established on July 8, 2004, and listed on September 24, 2020, is located in Shanghai and specializes in providing comprehensive steel logistics supply chain services for mid-to-high-end automotive and home appliance industries [2]. - The company's revenue composition includes 57.14% from processing and distribution, 41.95% from non-processing distribution, and 0.91% from processing and other services [2]. - Furan De operates within the transportation and logistics sector, focusing on raw material supply chain services, and is associated with concepts such as automotive lightweighting and new energy vehicles [2]. Group 3: Financial Performance - For the first half of 2025, Furan De reported a revenue of 5.215 billion CNY, reflecting a year-on-year growth of 2.25%, while the net profit attributable to shareholders was 153 million CNY, marking a 30.53% increase [2]. - The company has distributed a total of 784 million CNY in dividends since its A-share listing, with 532 million CNY distributed over the past three years [3]. - As of June 30, 2025, the number of shareholders decreased by 12.25% to 10,200, with an average of 48,259 circulating shares per shareholder, which increased by 13.95% [2].

Group 1 - The core viewpoint of the news is that Information Development has shown significant stock price growth and financial performance, with a notable increase in revenue despite a decline in net profit [1][2]. - As of September 16, the stock price of Information Development rose by 2.01% to 80.00 CNY per share, with a total market capitalization of 19.859 billion CNY [1]. - The company has experienced a stock price increase of 240.43% year-to-date, with a 17.82% rise in the last five trading days and a 154.21% increase over the past 60 days [1]. Group 2 - Information Development operates in the computer software development sector, specifically in vertical application software, and is associated with concepts such as Tencent Cloud and food and drug traceability [2]. - For the first half of 2025, the company reported revenue of 102 million CNY, representing a year-on-year growth of 38.29%, while the net profit attributable to shareholders was a loss of approximately 49.95 million CNY, a decrease of 29.84% compared to the previous year [2]. - The company has distributed a total of 31.2566 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3].

Company Overview - Sanofi Guojian is primarily engaged in the research, production, and sales of antibody drugs, with its main business revenue composition being 75.24% from product sales, 15.37% from commissioned processing services, 7.94% from licensing services, and 1.44% from leasing services [1] - The company was established on January 25, 2002, and was listed on July 22, 2020 [1] Financial Performance - For the first half of 2025, Sanofi Guojian achieved operating revenue of 642 million yuan, representing a year-on-year growth of 7.61%, and a net profit attributable to shareholders of 190 million yuan, which is a year-on-year increase of 46.96% [2] - Since its A-share listing, the company has distributed a total of 107 million yuan in dividends [3] Stock Market Activity - As of September 16, the stock price of Sanofi Guojian was 53.61 yuan per share, with a market capitalization of 33.066 billion yuan [1] - The stock has seen a year-to-date increase of 151.34%, but has experienced a decline of 4.05% over the last five trading days [1] - The company has appeared on the "Dragon and Tiger List" five times this year, with the most recent appearance on May 27, where it recorded a net purchase of 657,000 yuan [1] Shareholder Information - As of June 30, 2025, the number of shareholders of Sanofi Guojian was 12,800, an increase of 19.01% from the previous period, with an average of 48,028 circulating shares per person, a decrease of 15.97% [2] - Notable new institutional shareholders include ICBC Frontier Medical Stock A and China Europe Medical Health Mixed A, holding 3.199 million shares and 3.055 million shares respectively [3]

Core Viewpoint - The stock of TuoJing Life has experienced significant fluctuations, with a year-to-date increase of 88.23%, indicating strong market interest despite recent declines in share price and financial performance [1][2]. Financial Performance - For the first half of 2025, TuoJing Life reported revenue of 159 million yuan, a year-on-year decrease of 26.25%, and a net profit attributable to shareholders of 2.76 million yuan, down 58.41% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 264 million yuan, with 81.36 million yuan distributed over the past three years [3]. Stock Market Activity - As of September 16, TuoJing Life's stock price was 26.30 yuan per share, with a market capitalization of 4.275 billion yuan. The stock has seen a trading volume of 96.61 million yuan and a turnover rate of 2.63% [1]. - The stock has experienced a net outflow of 2.24 million yuan in principal funds, with significant buying and selling activity from large orders [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for TuoJing Life was 16,000, a decrease of 6.19% from the previous period, while the average number of circulating shares per person increased by 6.60% to 8,614 shares [2]. - Among the top ten circulating shareholders, CITIC Prudential Multi-Strategy Mixed Fund (LOF) A is a new entrant, holding 1.20 million shares [3]. Business Overview - TuoJing Life, established on November 6, 2003, and listed on April 21, 2017, specializes in the research, production, and sales of in vitro diagnostic products, with 92.50% of its revenue coming from reagent sales [1]. - The company operates within the pharmaceutical and biotechnology sector, specifically in medical devices and in vitro diagnostics [1].

Core Viewpoint - The stock price of China Merchants Shekou Industrial Zone Holdings Co., Ltd. has experienced fluctuations, with a current price of 9.50 CNY per share and a market capitalization of 86.08 billion CNY, reflecting a year-to-date decline of 5.44% [1] Financial Performance - For the first half of 2025, the company reported a revenue of 51.49 billion CNY, representing a year-on-year growth of 0.41%, and a net profit attributable to shareholders of 1.45 billion CNY, which is a 2.18% increase compared to the previous year [2] - Cumulatively, the company has distributed 38.997 billion CNY in dividends since its A-share listing, with 6.429 billion CNY distributed over the last three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 1.70% to 140,400, while the average circulating shares per person increased by 3.39% to 60,265 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 144 million shares, which decreased by 7.03 million shares from the previous period [3]

Company Overview - Zhejiang Xinhecheng Co., Ltd. is located in Xinchang County, Zhejiang Province, and was established on April 5, 1999. The company was listed on June 25, 2004. Its main business involves the production and sales of nutritional products, flavors and fragrances, high polymer new materials, and active pharmaceutical ingredients [1] - The revenue composition of Xinhecheng is as follows: Nutritional products 64.86%, Flavors and fragrances 18.96%, New materials 9.35%, Others 6.83% [1] Financial Performance - As of June 30, 2025, Xinhecheng achieved an operating income of 11.101 billion yuan, representing a year-on-year growth of 12.76%. The net profit attributable to shareholders was 3.603 billion yuan, showing a significant year-on-year increase of 63.46% [2] - Since its A-share listing, Xinhecheng has distributed a total of 15.502 billion yuan in dividends, with 5.071 billion yuan distributed over the past three years [3] Stock Market Activity - On September 16, Xinhecheng's stock price decreased by 2.03%, trading at 24.15 yuan per share, with a total market capitalization of 74.223 billion yuan. The trading volume was 255 million yuan, with a turnover rate of 0.34% [1] - Year-to-date, Xinhecheng's stock price has increased by 13.54%, with a 2.07% decline over the last five trading days, a 4.32% increase over the last 20 days, and a 12.33% increase over the last 60 days [1] Shareholder Structure - As of June 30, 2025, Xinhecheng had 80,700 shareholders, an increase of 3.59% from the previous period. The average number of circulating shares per shareholder was 37,616, a decrease of 3.47% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the second-largest shareholder with 192 million shares, an increase of 2.016 million shares from the previous period. Huatai-PB CSI 300 ETF is the fourth-largest shareholder with 27.4435 million shares, an increase of 2.2622 million shares [3]